Temazepam Capsule
Product Images NDC 70518-2487

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Temazepam (NDC 70518-2487). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Temazepam 15 mg oral capsules label showing a quantity of 100 capsules. The label includes the drug schedule designation C-IV, the labeler RemedyRepack Inc., and manufacturing information for Actavis in Sunrise, FL. Additional barcode and regulatory information are also present.*

FDA Label Image

Mm2 (Temazepam 15mg 70518 2487 01)

Label for Temazepam 15 mg oral capsule, single count, designated as C-IV controlled substance. Manufactured by Actavis in Sunrise, FL. Repackaged by RemedyRepack Inc., Indiana, PA. Includes NDC 70518-2487-01 and source NDC 00228-2076-10. Label states prescription use only and cautions about federal transfer restrictions.*

FDA Label Image

0c30f72b-figure-01 (Image 1)

Chemical structure of Temazepam, showing its molecular formula C16H13ClN2O2 and molecular weight 300.74.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.